WBR0713: Difference between revisions
Jump to navigation
Jump to search
Hardik Patel (talk | contribs) (Created page with "{{WBRQuestion |QuestionAuthor=William J Gibson |ExamType=USMLE Step 2 CK |MainCategory=Internal medicine |SubCategory=Cardiovascular |MainCategory=Internal medicine |SubCatego...") |
m (refreshing WBR questions) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{WBRQuestion | {{WBRQuestion | ||
|QuestionAuthor=William J Gibson | |QuestionAuthor=William J Gibson | ||
|ExamType=USMLE Step 2 CK | |ExamType=USMLE Step 2 CK | ||
| Line 25: | Line 25: | ||
'''Educational Objective:''' This patient has most likely been self-administering [[erythropoeitin]] as a performance enhancing drug. | '''Educational Objective:''' This patient has most likely been self-administering [[erythropoeitin]] as a performance enhancing drug. | ||
|AnswerA=Cocaine use | |AnswerA=Cocaine use | ||
|AnswerAExp='''Incorrect:''' Cocaine use has been associated with adverse cardiovascular effects and can cause [[ACS]], but the [[hematocrit]] of 65% is indicative of [[erythropoietin]] injection. | |AnswerAExp='''Incorrect:''' Cocaine use has been associated with adverse cardiovascular effects and can cause [[ACS]], but the [[hematocrit]] of 65% is indicative of [[erythropoietin]] injection. | ||
|AnswerB=Erythropoietin injection | |AnswerB=Erythropoietin injection | ||
|AnswerBExp='''Correct:''' This patient has most likely been self-administering [[erythropoietin]] as a performance enhancing drug. | |AnswerBExp='''Correct:''' This patient has most likely been self-administering [[erythropoietin]] as a performance enhancing drug. | ||
| Line 31: | Line 31: | ||
|AnswerCExp='''Incorrect:''' [[Familial hypercholesterolemia]] is characterized by very high [[LDL]] cholesterol and early cardiovascular disease running in families. | |AnswerCExp='''Incorrect:''' [[Familial hypercholesterolemia]] is characterized by very high [[LDL]] cholesterol and early cardiovascular disease running in families. | ||
|AnswerD=Hypertrophic cardiomyopathy | |AnswerD=Hypertrophic cardiomyopathy | ||
|AnswerDExp='''Incorrect:''' [[Hypertrophic cardiomyopathy]] is a leading cause of [[sudden cardiac death]] in young athlets, but in this case the [[hematocrit]] of 65% is indicative of [[erythropoietin]] injection. | |AnswerDExp='''Incorrect:''' [[Hypertrophic cardiomyopathy]] is a leading cause of [[sudden cardiac death]] in young athlets, but in this case the [[hematocrit]] of 65% is indicative of [[erythropoietin]] injection. | ||
|AnswerE=Polycythemia vera | |AnswerE=Polycythemia vera | ||
|AnswerEExp='''Incorrect:''' [[Polycythemia vera]] can | |AnswerEExp='''Incorrect:''' [[Polycythemia vera]] can cause similar presentation, but in this case of triathlete the [[hematocrit]] of 65% is indicative of [[erythropoietin]] injection. | ||
|RightAnswer=B | |RightAnswer=B | ||
|WBRKeyword=Blood doping | |WBRKeyword=Blood doping | ||
|Approved=Yes | |Approved=Yes | ||
}} | }} | ||
Latest revision as of 01:28, 28 October 2020
| Author | PageAuthor::William J Gibson |
|---|---|
| Exam Type | ExamType::USMLE Step 2 CK |
| Main Category | MainCategory::Internal medicine |
| Sub Category | SubCategory::Cardiovascular |
| Prompt | [[Prompt::A 30-year-old male competitive triathlete is brought to the emergency room after collapsing during a training run. He reports severe chest pain that radiates down his left arm. EKG shows ST-elevation in lead V1-V6 and cardiac enzymes are elevated. Routine labs are significant for a hematocrit of 65%. What is the most likely cause of this patient’s condition?]] |
| Answer A | AnswerA::Cocaine use |
| Answer A Explanation | [[AnswerAExp::Incorrect: Cocaine use has been associated with adverse cardiovascular effects and can cause ACS, but the hematocrit of 65% is indicative of erythropoietin injection.]] |
| Answer B | AnswerB::Erythropoietin injection |
| Answer B Explanation | [[AnswerBExp::Correct: This patient has most likely been self-administering erythropoietin as a performance enhancing drug.]] |
| Answer C | AnswerC::Familial hypercholesterolemia |
| Answer C Explanation | [[AnswerCExp::Incorrect: Familial hypercholesterolemia is characterized by very high LDL cholesterol and early cardiovascular disease running in families.]] |
| Answer D | AnswerD::Hypertrophic cardiomyopathy |
| Answer D Explanation | [[AnswerDExp::Incorrect: Hypertrophic cardiomyopathy is a leading cause of sudden cardiac death in young athlets, but in this case the hematocrit of 65% is indicative of erythropoietin injection.]] |
| Answer E | AnswerE::Polycythemia vera |
| Answer E Explanation | [[AnswerEExp::Incorrect: Polycythemia vera can cause similar presentation, but in this case of triathlete the hematocrit of 65% is indicative of erythropoietin injection.]] |
| Right Answer | RightAnswer::B |
| Explanation | [[Explanation::This patient has most likely been self-administering erythropoietin (EPO) as a performance enhancing drug. EPO is a naturally-occurring growth factor that stimulates the formation of RBCs. Easily injected under the skin, pharmaceutical EPO can boost hematocrit for six weeks or longer. EPO is also not free of health hazards: excessive use of the hormone can cause polycythemia, a condition where the level of RBCs in the blood is abnormally high. This causes the blood to be more viscous than normal, a condition that strains the heart and causes ACS. Some elite athletes who died of heart failure—usually during sleep, when heart rate is naturally low—were found to have unnaturally high RBC concentrations in their blood as in this case.
Educational Objective: This patient has most likely been self-administering erythropoeitin as a performance enhancing drug. |
| Approved | Approved::Yes |
| Keyword | WBRKeyword::Blood doping |
| Linked Question | Linked:: |
| Order in Linked Questions | LinkedOrder:: |